Hilary Marston

Hilary Marston, M.D., M.P.H., is the Chief Medical Officer (CMO) of the FDA. The CMO is the primary clinical advisor to the Commissioner and oversees the Office of Clinical Policy and Programs (OCPP). In this capacity, the CMO leads programs and cross-cutting initiatives that support the FDA’s centers in making effective, safe, and innovative medical products available to the American people.